Our Services - Best High-Risk Pregnancy & Obstetric Care Clinic in PCMC

High-risk pregnancies require specialized obstetric care and intensive monitoring. Dr. Rajendra Shitole's DGO and DNB training, combined with 11 years of experience, provides comprehensive management of pregnancy complications, maternal medical conditions, and fetal issues to ensure healthy outcomes.

What Defines a High-Risk Pregnancy?

A high-risk pregnancy is one in which maternal or fetal factors increase the likelihood of complications during pregnancy, labor, or delivery. Approximately 25-30% of pregnancies in developed countries are classified as high-risk, and the prevalence is likely similar or higher in India. Recognizing high-risk status early allows specialized care that significantly improves outcomes for both mother and baby.

Dr. Rajendra Shitole's expertise in obstetric management, grounded in formal training through DGO (Diploma in Obstetrics & Gynaecology) from BJ Government Medical College and Sassoon General Hospital in Pune and DNB (Diploma of National Board) in Obstetrics & Gynaecology from Sanjay Gandhi Memorial Hospital in New Delhi, ensures comprehensive evaluation and management of high-risk pregnancy. The concept of high-risk pregnancy encompasses diverse factors; a single risk factor might not dramatically elevate risk, but multiple factors combine to create significant complications risk. Maternal age is a primary risk factor - pregnancies in women under 18 or over 35 carry increased risks. Advanced maternal age (over 35) significantly increases risks of gestational diabetes, preeclampsia, and chromosomal abnormalities in the fetus.

Previous medical conditions including chronic hypertension, diabetes, heart disease, renal disease, or autoimmune conditions complicate pregnancy. Previous obstetric complications including previous cesarean sections, placental abruption, preeclampsia, or gestational diabetes indicate higher recurrence risk. Multiple pregnancy (twins, triplets) from fertility treatment or natural conception carries substantially higher risks of prematurity, growth restriction, and delivery complications.

Pregnancy complications developing during current pregnancy including gestational diabetes, preeclampsia, and placental insufficiency require specialized management. For women in PCMC and Pimpri Chinchwad, Dr. Shitole's approach begins with identifying all risk factors at the first prenatal visit, then creating individualized management plans addressing each woman's unique risk profile.

Maternal Age and Fertility Treatment as Risk Factors

Advanced maternal age - pregnancy at age 35 or older - is increasingly common as women pursue education and careers before childbearing. While healthy pregnancies occur at older maternal ages, age itself independently increases risks for complications. Women over 35 have increased risk of gestational diabetes (approximately double the baseline risk), preeclampsia, cesarean delivery, and stillbirth. Fetal risks include increased chromosomal abnormalities particularly Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), and Patau syndrome (trisomy 13). The risk of Down syndrome increases dramatically with age: at age 20, risk is approximately 1:1500; at age 35, approximately 1:350; at age 45, approximately 1:30.

These risks warrant comprehensive prenatal screening and counselling. Pregnancies achieved through fertility treatment deserve special attention. Multiple pregnancies (common after IVF, even though single-embryo transfer is increasingly used) significantly increase complications. Twin pregnancies have higher risks of preterm birth (average delivery at 35-36 weeks versus 39-40 weeks in singletons), growth restriction (particularly twin-to-twin transfusion syndrome in monochorionic twins), and cesarean delivery. Careful ultrasound monitoring of multiple pregnancies, beginning with early assessment of chorionicity (whether twins share a placenta), guides appropriate management.

Dr. Shitole's experience with fertility treatment patients means he understands the special needs of women who conceived through IVF or other assisted reproduction - they often have underlying fertility issues, advanced age, or multiple pregnancies requiring additional monitoring. At DPU Hospital in Pimpri, women in PCMC who conceived through fertility treatment receive specialized care addressing their unique risk profile.

Gestational Diabetes and Metabolic Complications

Gestational diabetes mellitus (GDM), glucose intolerance first detected during pregnancy, affects 5-20% of pregnancies depending on screening and diagnostic criteria used. The condition significantly increases risks for maternal and fetal complications if not appropriately managed. Risk factors for gestational diabetes include maternal age over 25, obesity (BMI over 30), family history of diabetes, sedentary lifestyle, and previous gestational diabetes.

The pathophysiology involves increased insulin resistance during pregnancy due to placental hormones antagonizing insulin action. In women with limited beta-cell reserve (genetic predisposition to diabetes), this pregnancy-induced insulin resistance exceeds their ability to compensate, resulting in hyperglycemia. Gestational diabetes screening occurs at 24-28 weeks of pregnancy through either a one-step 75-gram glucose tolerance test or a two-step approach with initial 50-gram glucose challenge followed by confirmatory 75-gram tolerance test if initial screening is positive. Diagnosis requires meeting established glucose thresholds; specific values vary by guideline. Once diagnosed, gestational diabetes requires active management to prevent complications.

Maternal complications include increased risk of preeclampsia, cesarean delivery, and subsequent type 2 diabetes (approximately 50% of women with GDM develop type 2 diabetes within 10 years postpartum). Fetal complications include macrosomia (excessive fetal growth), leading to birth trauma and obesity in childhood. Maternal hyperglycemia causes fetal hyperglycemia, stimulating excessive fetal insulin production, which promotes fat accumulation and large birth weight. Neonatal complications include hypoglycemia (low blood sugar in newborn due to excessive insulin), hypocalcemia, hyperbilirubinemia, and respiratory distress syndrome.

Management of gestational diabetes starts with medical nutrition therapy and lifestyle modifications. A diabetic diet emphasizing complex carbohydrates, fiber, moderate protein, and controlled portion sizes, combined with regular physical activity (30 minutes moderate activity 5 days weekly) improves glucose control in many women. Blood glucose monitoring (typically 4 times daily - fasting and 2 hours after each meal) allows assessment of diet effectiveness. Many women achieve adequate glucose control through diet alone.

Those not achieving target glucose levels (fasting less than 95 mg/dl, 2-hour postprandial less than 120-140 mg/dl depending on protocol) require insulin therapy - the safest medication for glucose control in pregnancy. Oral agents are avoided because of limited safety data. Fetal monitoring with twice-weekly non-stress tests and ultrasound assessment of fetal growth occurs in the third trimester in women with insulin-treated gestational diabetes. Delivery timing, typically 39 weeks in uncomplicated gestational diabetes managed with diet, might be advanced in those requiring insulin or with other complications.

For women in PCMC with gestational diabetes, Dr. Shitole's approach ensures optimal glucose control, appropriate monitoring, and delivery planning that minimizes complications for mother and baby.

Preeclampsia and Hypertensive Disorders

Preeclampsia, a pregnancy-specific hypertensive disorder, affects 5-8% of pregnancies and remains a leading cause of maternal morbidity and mortality globally. The condition is defined by new-onset hypertension (blood pressure ≥140/90 mmHg on two occasions) developing after 20 weeks of gestation, combined with signs of end-organ damage. Proteinuria (protein in urine) was historically required but is no longer strictly required if other organ dysfunction is present. Risk factors for preeclampsia include primigravidity (first pregnancy), advanced maternal age, obesity, chronic hypertension, diabetes, kidney disease, autoimmune disease, previous preeclampsia (recurrence risk 20-30%), multiple pregnancy, and thrombophilia.

The pathophysiology involves abnormal placental development with insufficient trophoblastic invasion into maternal spiral arteries, resulting in placental ischemia and release of vasoconstrictor substances. This creates endothelial dysfunction, leading to the characteristic multi-system involvement of preeclampsia. Maternal complications include hypertensive crisis, pulmonary edema, cerebral edema, stroke, placental abruption, disseminated intravascular coagulation, kidney failure, and liver failure. Eclampsia (seizures) is the most dramatic manifestation. Maternal death from preeclampsia remains possible even in developed settings and is more common in resource-limited areas.

Fetal complications include placental insufficiency resulting in growth restriction, preterm birth (delivery at less than 37 weeks), fetal distress, and intrauterine fetal death. Neonatal complications include respiratory distress, hypoglycemia, and complications of prematurity. Management of preeclampsia depends on severity and gestational age. Preeclampsia without severe features at less than 37 weeks often continues pregnancy under intensive monitoring - blood pressure checks twice weekly, laboratory assessment of kidney function and liver function weekly, and fetal monitoring with non-stress tests twice weekly.

Antihypertensive medications maintaining blood pressure at safe levels (typically 140-150 systolic, 90-100 diastolic) protect maternal organs without excessively reducing placental perfusion. Corticosteroids (betamethasone) are administered if delivery is anticipated before 34 weeks to accelerate fetal lung maturation. Severe preeclampsia or eclampsia at any gestation, or any preeclampsia after 34 weeks, generally warrants delivery as definitive treatment. Labor induction or cesarean delivery is performed, with careful blood pressure management and seizure prophylaxis with magnesium sulfate.

For women in PCMC with hypertension or preeclampsia risk, Dr. Shitole's expertise ensures vigilant monitoring and timely intervention preventing maternal and fetal catastrophe.

Multiple Pregnancy Management and Complications

Multiple pregnancies, whether from fertility treatment or natural conception, represent a distinct high-risk category requiring specialized management. Twins occur naturally in approximately 1:30 births but are more common after assisted reproduction technology, particularly with multiple embryo transfer. Triplets and higher multiples have become less common with widespread adoption of single-embryo transfer but remain possible. Multiple pregnancy complications include higher maternal risk of gestational diabetes, preeclampsia, anemia, and postpartum hemorrhage.

Fetal complications include prematurity (average delivery at 35-36 weeks in twins versus 39-40 weeks in singletons), intrauterine growth restriction, birth defects (higher absolute risk due to two fetuses), and perinatal mortality (2-3 times higher than singletons). The type of multiple pregnancy (chorionicity) significantly affects outcomes. Dichorionic diamniotic twins (two placentas, two amniotic sacs) have lowest risk and outcomes similar to singletons if weight-discordant cases are excluded.

Monochorionic diamniotic twins (one placenta, two amniotic sacs) have increased complications including twin-to-twin transfusion syndrome (TTTS), where abnormal vascular connections allow disproportionate blood flow from one twin (donor) to the other (recipient). The donor twin becomes anemic and growth-restricted; the recipient becomes hypervolemic and polyhydramnios develops. TTTS, detected through ultrasound, increases perinatal mortality and morbidity significantly. Treatment options include expectant management with intensive monitoring, therapeutic amniocentesis (removing excess amniotic fluid from the recipient), or laser ablation of abnormal vascular connections (most effective).

Monochorionic monoamniotic twins (one placenta, one amniotic sac) have the highest risk due to cord entanglement; pregnancy management typically involves hospitalization for continuous monitoring in the third trimester. Initial prenatal ultrasound determines chorionicity, and this information guides entire pregnancy management. Prenatal monitoring of multiple pregnancies includes frequent ultrasounds assessing fetal growth, amniotic fluid volume, and signs of complications, non-stress tests beginning at 28-30 weeks, and careful assessment of delivery timing to optimize neonatal outcomes.

Delivery planning considers fetal weight, presentation, and gestational age; hospital delivery at a facility with neonatal intensive care capability is essential. For women in PCMC with multiple pregnancies from fertility treatment, Dr. Shitole's comprehensive approach from early pregnancy through delivery ensures optimal outcomes.

Previous Obstetric Complications and Their Management

Women with previous obstetric complications deserve intensive management in subsequent pregnancies because many complications recur. Previous cesarean section affects approximately 20-30% of women in developed countries and an increasing proportion in India. While vaginal delivery after cesarean (VBAC) is often possible, a repeat cesarean is common due to either patient preference or physician recommendation. The risks of planned repeat cesarean versus trial of labor include benefits of VBAC (avoiding major surgery, faster recovery, fewer maternal complications) but also risks of uterine rupture (0.5-1% in women with previous low-transverse cesarean) and perinatal complications if rupture occurs.

Dr. Shitole counsels women thoroughly about VBAC feasibility based on reason for previous cesarean, number of previous cesareans, and presence of other risk factors. Women who achieve VBAC have excellent outcomes and no increased risk with subsequent pregnancies. Previous preeclampsia increases recurrence risk to 20-30%, and severe preeclampsia or early-onset preeclampsia carries higher recurrence risk. Management of women with previous preeclampsia includes low-dose aspirin (81 mg daily) starting at 12-16 weeks, which reduces recurrence risk by approximately 17-20%.

Calcium supplementation (1500 mg daily) may provide additional benefit. Intensive blood pressure monitoring, more frequent prenatal visits, and low threshold for delivery are standard. Previous placental abruption (placenta separates prematurely from uterine wall) carries approximately 5-10% recurrence risk, and counselling about warning signs (vaginal bleeding, abdominal pain, contractions) is essential. Fetal monitoring is intensified, particularly in the third trimester. Previous gestational diabetes increases risk of recurrence to 30-50%, and pre-existing diabetes develops in 20-30% of women with prior GDM.

Aggressive screening and management are critical. Previous intrauterine fetal death (stillbirth) is profoundly traumatic and carries recurrence risk of approximately 5% if no cause was identified. Management includes intensified surveillance with twice-weekly non-stress tests beginning at viability and delivery at 39 weeks. For women in PCMC with previous complicated pregnancies, Dr. Shitole's approach combines realistic counselling with evidence-based interventions minimizing recurrence risk and optimizing outcomes.

Placental and Fetal Issues in High-Risk Pregnancy

Placental insufficiency, where the placenta fails to adequately deliver oxygen and nutrients to the fetus, is a major cause of complications in high-risk pregnancy. The placenta develops abnormally in some women (particularly those with hypertension, preeclampsia, or diabetes), resulting in inadequate blood flow. Placental insufficiency manifests as intrauterine growth restriction (IUGR), where the fetus fails to grow at expected rate. IUGR detected through ultrasound shows abdominal circumference and estimated fetal weight below 10th percentile for gestational age. Severe IUGR with absent or reversed end-diastolic flow in the umbilical artery indicates severe placental dysfunction and fetal compromise.

Fetal hypoxia develops, potentially leading to fetal distress, nonreassuring fetal heart rate patterns, and perinatal death if not managed appropriately. Management of IUGR depends on severity and gestational age. At less than 34 weeks, expectant management with intensive monitoring (twice-weekly or more frequent ultrasounds, frequent non-stress tests) attempts to continue pregnancy allowing fetal growth and maturation while minimizing harm from fetal hypoxia. Corticosteroids are administered for fetal lung maturation. If signs of severe fetal compromise develop (absent flow in umbilical artery, abnormal venous Doppler), delivery is indicated despite prematurity.

At 34 weeks or beyond, delivery is usually recommended because fetal benefits of further gestation are outweighed by risks of continuing pregnancy with compromised placental function. Abnormal placentation, including placenta previa (placenta covering the cervical os), placenta accreta (abnormal invasion of the placenta into the uterine wall), and vasa previa (exposed fetal blood vessels crossing membranes), requires specialized management. Placenta previa diagnosed in the first or second trimester often resolves as the uterus grows, but if present at delivery, cesarean is necessary (vaginal delivery with placenta previa results in massive hemorrhage).

Placenta accreta, increasingly common after previous cesarean, requires careful planning for delivery; facilities with capacity for emergency hysterectomy and blood transfusion are essential. Cesarean delivery at a tertiary center with surgical expertise and blood product availability is recommended. For women in PCMC with placental or fetal issues, DPU Hospital provides comprehensive ultrasound assessment and subspecialty care ensuring optimal pregnancy outcomes.

DPU Hospital's High-Risk Pregnancy Infrastructure

High-risk pregnancy requires facilities and expertise supporting intensive monitoring and emergency obstetric care. DPU Hospital in Pimpri provides this level of infrastructure, making it an excellent choice for women in PCMC requiring specialized obstetric management. The obstetric department includes dedicated high-risk pregnancy clinics with frequent monitoring appointments. State-of-the-art ultrasound equipment allows detailed assessment of fetal anatomy, growth, and well-being.

Doppler ultrasound assesses placental function and fetal perfusion in pregnancies with growth restriction or preeclampsia. Continuous fetal heart rate monitoring (cardiotocography) allows assessment of fetal well-being during labor and in antepartum settings. Multiple operating rooms in the labor and delivery unit enable rapid cesarean delivery if fetal compromise or maternal complications develop. Anesthesia services available 24/7 provide safe anesthesia for cesarean delivery or emergency procedures. Blood bank services ensure ready availability of blood products for women at risk of excessive bleeding.

Intensive care unit capacity allows management of severe maternal complications including eclampsia, HELLP syndrome (hemolysis, elevated liver enzymes, low platelets), disseminated intravascular coagulation, and other serious conditions. Neonatal intensive care unit (NICU) on-site provides immediate care for premature or compromised newborns. Neonatologists and trained nursing staff manage respiratory support, temperature regulation, nutrition, and other critical care needs.

The combination of skilled obstetric team, comprehensive monitoring capability, emergency surgical capacity, intensive care resources, and neonatal expertise creates the optimal environment for high-risk pregnancy care. Dr. Rajendra Shitole's coordination of care, supported by this infrastructure, provides women in PCMC with the highest standard of high-risk pregnancy management.